Page 2 - Ingmar Hoerr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

pocket „Es ist eine Vision – aber ich bin sehr zuversichtlich“, sagt Wolfgang Hilbe, Leiter der 1. Med. Abteilung (Zentrum für Onkologie und Hämatologie) in der Klinik Ottakring in Wien - und meint die Entwicklung von Impfstoffen gegen Krebs, die so funktionieren könnten. Hilbe erklärt, wie so eine Therapie ablaufen könnte: Bei einem Patienten wird ein Tumor diagnostiziert, er wird operiert, Tumorzellen werden an eine mRNA-Impfstoff-Firma geschickt. Dort werden die typischen Merkmale an der Oberfläche der Krebszellen (Proteine bzw. Proteinteile) identifiziert. Mit einem Computerpr...

Covid Vaccine From Germany's CureVac Just 48% Effective By Michelle FITZPATRICK 06/30/21 AT 7:58 PM Germany's CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna. The outcome had been expected after poor interim data were released earlier this month. The company in part blamed "the unprecedented context of 15 strains circulating" among the trial volunteers, as well as varying responses across age groups. The Covid vaccines developed by Germany's Bio...

Germany's CureVac Covid vaccine only 48% effective Thu, Jul 01, 2021 FRANKFURT: Germany´s CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna. The outcome had been expected after poor interim data were released earlier this month. The company in part blamed "the unprecedented context of 15 strains circulating" among the trial volunteers, as well as varying responses across age groups. The Covid vaccines developed by Germany´s BioNTech in partnership ...

' + activeFrame.title + ' '); $(".fotorama-caption").addClass("add_caption"); $(".fotorama-caption").removeClass("remove_caption"); } else { // alert("hide div"); $(".fotorama-caption").addClass("remove_caption"); $(".fotorama-caption").removeClass("add_caption"); } }) .fotorama(); COVID vaccine from Germany's CureVac just 48% effective – final results Wednesday, June 30, 2021 FRANKFURT, Germany (AFP)— Germany's CureVac announced Wednesday that final trial results showed its c...

Covid vaccine from Germany's CureVac just 48% effective Thu 01st July 2021 | 08:50 AM Frankfurt, (UrduPoint / Pakistan Point News - 1st Jul, 2021 ) :Germany's CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna. The outcome had been expected after poor interim data were released earlier this month. The company in part blamed "the unprecedented context of 15 strains circulating" among the trial volunteers, as well as varying responses across age grou...